{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:30:29Z","timestamp":1782333029191,"version":"3.54.5"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Type-2 diabetes is characterized by glycosuria, hyperglycemia, glucose intolerance, hyperinsulinemia, and insulin resistance. One or several among these alterations are also found after starvation, ketogenic diet, and pharmacological treatment with rapamycin or antibody-mediated neutralization of the obesogenic factor ACBP\/DBI. Thus, a variety of metabolic interventions that improve metabolic health can induce a transient state of \u201cpseudo-diabetes\u201d.<\/jats:p>","DOI":"10.1038\/s41419-019-2007-1","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T12:41:30Z","timestamp":1570711290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pseudodiabetes\u2014not a contraindication for metabolic interventions"],"prefix":"10.1038","volume":"10","author":[{"given":"Jos\u00e9 Manuel","family":"Bravo-San Pedro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Sica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"2007_CR1","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.cell.2016.07.031","volume":"166","author":"C Lopez-Otin","year":"2016","unstructured":"Lopez-Otin, C., Galluzzi, L., Freije, J. M. P., Madeo, F. & Kroemer, G. Metabolic control of longevity. Cell 166, 802\u2013821 (2016).","journal-title":"Cell"},{"key":"2007_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2018.07.044","volume":"175","author":"G Kroemer","year":"2018","unstructured":"Kroemer, G., Lopez-Otin, C., Madeo, F. & de Cabo, R. Carbotoxicity-noxious effects of carbohydrates. Cell 175, 605\u2013614 (2018).","journal-title":"Cell"},{"key":"2007_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2009.8","volume":"1","author":"E Morselli","year":"2010","unstructured":"Morselli, E. et al. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis. 1, e10 (2010).","journal-title":"Cell Death Dis."},{"key":"2007_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/15548627.2016.1271513","volume":"13","author":"F Pietrocola","year":"2017","unstructured":"Pietrocola, F. et al. Metabolic effects of fasting on human and mouse blood in vivo. Autophagy 13, 567\u2013578 (2017).","journal-title":"Autophagy"},{"key":"2007_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nature10758","volume":"481","author":"C He","year":"2012","unstructured":"He, C. et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis. Nature 481, 511\u2013515 (2012).","journal-title":"Nature"},{"key":"2007_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.373","volume":"8","author":"AF Fernandez","year":"2017","unstructured":"Fernandez, A. F. et al. Autophagy couteracts weight gain, lipotoxicity and pancreatic beta-cell death upon hypercaloric pro-diabetic regimens. Cell Death Dis. 8, e2970 (2017).","journal-title":"Cell Death Dis."},{"issue":"6374","key":"2007_CR7","doi-asserted-by":"publisher","first-page":"eaan2788","DOI":"10.1126\/science.aan2788","volume":"359","author":"Frank Madeo","year":"2018","unstructured":"Madeo, F., Eisenberg, T., Pietrocola, F. & Kroemer, G. Spermidine in health and disease. Science 359, https:\/\/doi.org\/10.1126\/science.aan2788 (2018).","journal-title":"Science"},{"key":"2007_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1822-8","volume":"10","author":"MV Blagosklonny","year":"2019","unstructured":"Blagosklonny, M. V. Fasting and rapamycin: diabetes versus benevolent glucose intolerance. Cell Death Dis. 10, 607 (2019).","journal-title":"Cell Death Dis."},{"issue":"4","key":"2007_CR9","doi-asserted-by":"publisher","first-page":"754-767.e9","DOI":"10.1016\/j.cmet.2019.07.010","volume":"30","author":"Jos\u00e9 M. Bravo-San Pedro","year":"2019","unstructured":"Bravo-San Pedro, J. M. et al. Acyl-CoA-binding protein is a lipogenic factor that triggers food intake and obesity. Cell Metab., https:\/\/doi.org\/10.1016\/j.cmet.2019.07.010 (2019).","journal-title":"Cell Metabolism"},{"issue":"11","key":"2007_CR10","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1080\/15548627.2019.1662585","volume":"15","author":"Jos\u00e9 Manuel Bravo-San Pedro","year":"2019","unstructured":"Bravo-San Pedro, J. M. et al. Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI\/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor. Autophagy, https:\/\/doi.org\/10.1080\/15548627.2019.1662585 (2019).","journal-title":"Autophagy"},{"key":"2007_CR11","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1080\/15384101.2019.1644765","volume":"18","author":"MV Blagosklonny","year":"2019","unstructured":"Blagosklonny, M. V. The mystery of the ketogenic diet: benevolent pseudo-diabetes. Cell Cycle 18, 2157\u20132163 (2019).","journal-title":"Cell Cycle"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2007-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:42:58Z","timestamp":1671212578000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2007-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":11,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["2007"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-2007-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"10 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M.B.-S.P. and G.K. filed a patent application dealing with targeting the ACBP\/DBI system in anorexia, obesity, and co-morbidities. G.K. filed additional patent applications dealing with caloric restriction mimetics (autophagy inducers) for the treatment of aging, age-related diseases, cancer, obesity, and co-morbidities. G.K. is a scientific co-founder of Samsara Therapeutics and Therafast Bio.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"765"}}